PSI CRO - Contract Research Organization

   |   

   |   

   |   

   |   


HOME
ABOUT US
FULL SERVICE CRO
GLOBAL REACH
ON-TIME ENROLLMENT
THERAPEUTIC EXCELLENCE
NEWS

Clinical Trial News     |     Social Media     |     PSI Newsletters     |     PSI Newsletter Articles

You are here:   Home > News > Newsletter Articles
Email Page Print Page


Enrollment Rxpert: Drugs And Drugs

Enrollment Rxpert: Drugs And Drugs

Opioid dependence is a morbid addiction consisting in compulsive drug use, preoccupying drug-seeking behavior, progressive abandonment of alternative pleasures and interests, as well as persistent substance abuse despite abundant evidence of overtly detrimental consequences.
Enrollment Rxpert: Drugs And Drugs
Project Management

Project Management

Did you know that PSI employs 50 Project Managers globally? And that most of them have a medical background?
Project Management
Enrollment RxPert: Liquidity Report

Enrollment RxPert: Liquidity Report

Hematologic malignancies are cancers that affect the blood, bone marrow, and lymph nodes. These neoplasms are sometimes loosely referred to as “blood cancer” or “liquid tumors”; these clinical colloquialisms are manifestly imprecise but, for historical reasons, they are part of common medical parlance.
Enrollment RxPert: Liquidity Report
Enrollment RxPert: The Pink Day

Enrollment RxPert: The Pink Day

Breast cancer is the most common invasive cancer in women, comprising more than 20% of all female cancers. The incidence of this disease is inversely correlated with the level of economic and social development in a given region of the world, being the highest in North America and the lowest in East Asia.
Enrollment RxPert: The Pink Day
Hungarian Waltz to FPI

Hungarian Waltz to FPI

Time to First-Patient-In varies across Europe and can turn into a long wait in some of the countries. From our experience, Hungary has always been able to offer rather swift and predictable review timelines. That, supplemented by steady, reliable patient enrollment in most indications, makes Hungary an indispensable country for running clinical trials.
Hungarian Waltz to FPI
The Year Of Communication At PSI

The Year Of Communication At PSI

Over the years, PSI has expanded our services to 35+ countries, covering and connecting regions separated by whole time zones, globally. With the addition of countries, comes the challenge of learning new ways of communicating, new ways of conducting business, and new ways of cooperating with one another.
The Year Of Communication At PSI
38 FDA inspections came and went… happy!

38 FDA inspections came and went… happy!

PSI has hosted FDA and EMA inspections in several of the 35+ countries in which we operate. To date, the FDA has audited study data at PSI- managed trial sites 38 times! We are extremely proud of the fact that even with such a high volume of audits we have aced the inspections with no major findings.
38 FDA inspections came and went… happy!
Trials in Latin America? Absolutamente!

Trials in Latin America? Absolutamente!

Latin America represents a very important region for PSI. It keeps demonstrating vast patient enrollment capacity and high quality data, as verified through FDA audits of PSI sites in different Latin American countries.
Trials in Latin America? Absolutamente!
Enrollment Expert: The Biggest of the Big C’s

Enrollment Expert: The Biggest of the Big C’s

Lung cancer is the most common cause of cancer-related death in men and women worldwide. It is a devastating and poorly treatable disease: the 5-year survival rate dwindles around 15%, and the annual death toll exceeds 1.3 million globally.
Enrollment Expert: The Biggest of the Big C’s
About PSI Full Service CRO Global Reach On-Time Enrollment Therapeutic Excellence News
Full Name
Email
Details

© PSI, 1995-2013. All rights reserved. | Terms of Access | Disclaimer | Privacy Policy | Sitemap

PSI on Xing PSI on Twitter PSI on Facebook PSI on Linkedin PSI on YouTube News Archives